Study Identifies NSCLC Patients Who Are More Likely to Have Improved Progression-Free Survival on Third-Generation EGFR-TKI Therapy - Clinical Lab Products

摘要

Theblood-basedproteomictesthelpsidentifynon-smallcelllungcancerpatientsforepidermalgrowthfactorreceptortyrosinekinaseinhibitortherapy.